Literature DB >> 26403216

Atypical central retinal artery occlusion: an uncommon cause of retinopathy and visual loss in dermatomyositis.

Mukta Sharma1, Aditi Prashar1, Rajiv Tuli1, Rattan K Sharma1, Vikram K Mahajan2.   

Abstract

Several ophthalmic manifestations in patients with dermatomyositis have been described but involvement of the retina is rare. A 39-year-old man diagnosed with dermatomysitis had developed sudden painless visual loss in the left eye. He was non-diabetic and non-hypertensive. He was on treatment with systemic prednisolone (50 mg/day) and methotrexate (7.5 mg/day) for dermatomyositis. His visual acuity was finger counting at 2 feet in the left eye and 6/6 in the right eye. Left fundus showed slight blurring of the optic disc margins, large peripapillary flame-shaped haemorrhages and extensive area of opacification suggestive of central retinal artery occlusion (CRAO) with sparing of the area supplied by the cilioretinal artery. The exact pathomechanism of CRAO in dermatomyositis remains poorly elucidated. The infarctive events following endothelial damage and platelet thrombi occurring in arterioles and capillaries of retina, optic disc and choriocapillaries causing ischemia/infarction have been suggested as possible reasons. However, central artery occlusion from high intraocular pressure from marked (heliotrope) orbital edema appears more plausible in our case. The degree of retinal damage is variable when CRAO lasts between 105 and 240 min and irreversible profound visual loss may occur from its occlusion lasting for more than 240 min. A prompt ophthalmological opinion/management is recommended to limit its progression.
© 2015 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  dermatomyositis; retinopathy; visual loss

Mesh:

Substances:

Year:  2015        PMID: 26403216     DOI: 10.1111/1756-185X.12750

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  5 in total

Review 1.  Polymyositis and dermatomyositis: ocular manifestations and potential sight-threatening complications.

Authors:  Raul E Ruiz-Lozano; Fabiola Velazquez-Valenzuela; Mariana Roman-Zamudio; Salma K Andrade-Leal; Alejandro Rodriguez-Garcia
Journal:  Rheumatol Int       Date:  2021-10-21       Impact factor: 2.631

2.  Ophthalmic manifestations in patients with collagen vascular disorders: a hospital-based retrospective observational study.

Authors:  Surinder Kumar Sharma; Anju Lath Sharma; Vikram K Mahajan
Journal:  Int Ophthalmol       Date:  2021-04-08       Impact factor: 2.031

3.  The pulseless patient: Profound vasculopathy as the presenting feature of fulminant dermatomyositis and response to therapy.

Authors:  Farzam Gorouhi; Maija Kiuru; Marc Silverstein; Parisa Emami-Naeini; Susanna S Park; Danielle Tartar
Journal:  JAAD Case Rep       Date:  2019-01-30

Review 4.  Epidemiology of Ocular Manifestations in Autoimmune Disease.

Authors:  Katie Glover; Deepakkumar Mishra; Thakur Raghu Raj Singh
Journal:  Front Immunol       Date:  2021-11-02       Impact factor: 7.561

5.  Observation on therapeutic efficacy of rt-PA intravenous thrombolysis combined with compound anisodine injection on central retinal artery occlusion.

Authors:  Xiao-Jun Wu; Feng Gao; Xu Liu; Qing Zhao
Journal:  Exp Ther Med       Date:  2016-09-07       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.